Concepedia

Anneleen Van Hout

AV

Statistics

Publications

7

Citations

246

H-Index

7

Active since

2017

Affiliations

Rega Institute for Medical Research(Current)

KU Leuven

Vrije Universiteit Amsterdam

Ablynx (Belgium)

Anneleen Van Hout is an author at Rega Institute for Medical Research specializing in cell signaling, ligand binding, and life sciences.

ORCID

Publications per year

2017–2020

7

Publications

7

Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions

Vladimir Bobkov, Aurélien Zarca, Anneleen Van Hout et al. · Biochemical Pharmacology · 2018 · 72 citations · Full text

, , +17

CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry

Anneleen Van Hout, Vladimir Bobkov, Jordi Doijen et al. · Biochemical Pharmacology · 2018 · 59 citations · Full text

, , +16

Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors

Anneleen Van Hout, Thomas D’huys, Merel Oeyen et al. · PLoS ONE · 2017 · 51 citations · Full text

, , +17

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Geert Schoofs, Anneleen Van Hout, Thomas D’huys et al. · Journal of Visualized Experiments · 2018 · 22 citations · Full text

, , +17

Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines

Maaike Cockx, Mieke Gouwy, Pieter Ruytinx et al. · Scientific Reports · 2017 · 17 citations · Full text

, , +17

1–5 of 7